Recent research has broadened its applications beyond metabolism, highlighting its synergistic potential with NAD+ therapy for anti-aging and longevity benefits.[6][7] For instance, studies in adipocytes have demonstrated that 5-Amino-1MQ can increase NAD+ levels by 1.2 to 1.6-fold, suggesting a direct role in cellular rejuvenation.[8] This evidence prompted HyperCharge Health to incorporate NAD+ therapy with 5-Amino-1MQ, particularly for adults over 40, where NAD+ levels may have dropped by 50% or more.[9][10] At our clinics, we've observed patients reporting not just improved energy but also enhanced skin elasticity and reduced inflammation markers after combining these therapies
P16INK4a upregulation mediated by SIX6 defines retinal ganglion cell pathogenesis in glaucoma
If a researcher observes an effect using GLOW, they cannot attribute it to any one component, cannot construct a dose-response for the components independently, and cannot compare their ratio to anyone elses because the ratio is proprietary and often undisclosed
The third pathway is proline utilisation which occurs in mitochondria where proline is oxidised to pyrroline-5-carboxylate by mitochondrial proline dehydrogenase ( PUT1 ) which, in turn, is further oxidised to glutamate by 1-pyrroline-5-caboxylate dehydrogenase ( PUT2 ) 19